Radio and PodcastRadio and PodcastLive Radio & Podcasts
A Breakthrough in Pancreatic Cancer Treatment – KRAS Targeting and Daraxonrasib artwork
Health

A Breakthrough in Pancreatic Cancer Treatment – KRAS Targeting and Daraxonrasib

CancerCast by Weill Cornell Medicine

Aug 28, 202600:32:13Health

Pancreatic cancer treatment has entered an exciting new chapter. On August 26, 2026, the U.S. Food and Drug Administration (FDA) approved the oral medication daraxonrasib for metastatic pancreatic cancer. This represents...